Financial Enhancement Group LLC Danaher Corp Transaction History

Financial Enhancement Group LLC

$569 Million
Q3 2024

A detailed history of Financial Enhancement Group LLC transactions in Danaher Corp stock. As of the latest transaction made, Financial Enhancement Group LLC holds 11,081 shares of DHR stock, worth $2.53 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

11,081

Previous 10,440 6.14%

Holding current value

$2.53 Million

Previous $2.61 Million 18.1%

% of portfolio

0.54%

Previous 0.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$239.25 - $280.76 $153,359 - $179,967	641 Added 6.14%	11,081 $3.08 Million
Q2 2024 Aug 02, 2024	SELL	$235.51 - $267.98 $6,594 - $7,503	-28 Reduced 0.27%	10,440 $2.61 Million
Q1 2024 Apr 15, 2024	BUY	$224.58 - $256.19 $1,122 - $1,280	5 Added 0.05%	10,468 $2.61 Million
Q4 2023 Jan 18, 2024	SELL	$185.1 - $233.13 $29,245 - $36,834	-158 Reduced 1.49%	10,463 $2.42 Million
Q3 2023 Oct 17, 2023	SELL	$233.08 - $265.59 $4,661 - $5,311	-20 Reduced 0.19%	10,621 $2.64 Million
Q2 2023 Aug 10, 2023	SELL	$224.99 - $256.14 $98,995 - $112,701	-440 Reduced 3.97%	10,641 $2.55 Million
Q1 2023 May 17, 2023	SELL	$239.75 - $277.0 $11,268 - $13,019	-47 Reduced 0.42%	11,081 $2.79 Million
Q4 2022 Feb 09, 2023	BUY	$241.42 - $282.29 $10,381 - $12,138	43 Added 0.39%	11,128 $2.95 Million
Q3 2022 Oct 27, 2022	SELL	$247.06 - $1507.4 $146,506 - $893,888	-593 Reduced 5.08%	11,085 $2.86 Million
Q2 2022 Aug 09, 2022	BUY	$237.11 - $299.66 $158,152 - $199,873	667 Added 6.06%	11,678 $2.96 Million
Q1 2022 May 18, 2022	BUY	$257.27 - $315.76 $29,328 - $35,996	114 Added 1.05%	11,011 $3.23 Million
Q4 2021 Jan 28, 2022	SELL	$292.08 - $329.01 $30,084 - $33,888	-103 Reduced 0.94%	10,897 $3.59 Million
Q3 2021 Oct 14, 2021	BUY	$272.21 - $332.43 $83,840 - $102,388	308 Added 2.88%	11,000 $3.35 Million
Q2 2021 Aug 10, 2021	SELL	$225.08 - $271.69 $262,443 - $316,790	-1,166 Reduced 9.83%	10,692 $2.87 Million
Q1 2021 May 10, 2021	SELL	$212.38 - $245.9 $228,520 - $264,588	-1,076 Reduced 8.32%	11,858 $2.67 Million
Q4 2020 Feb 10, 2021	SELL	$212.5 - $245.46 $44,412 - $51,301	-209 Reduced 1.59%	12,934 $2.87 Million
Q3 2020 Nov 18, 2020	SELL	$177.16 - $215.33 $99,563 - $121,015	-562 Reduced 4.1%	13,143 $2.83 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $145,945 - $200,525	-1,134 Reduced 7.64%	13,705 $2.42 Million
Q1 2020 May 04, 2020	SELL	$121.39 - $169.05 $1.19 Million - $1.66 Million	-9,841 Reduced 39.87%	14,839 $2.05 Million
Q4 2019 Jan 31, 2020	SELL	$133.47 - $153.48 $73,141 - $84,107	-548 Reduced 2.17%	24,680 $3.79 Million
Q3 2019 Nov 08, 2019	SELL	$135.4 - $146.47 $117,121 - $126,696	-865 Reduced 3.32%	25,228 $3.64 Million
Q2 2019 Aug 06, 2019	SELL	$124.88 - $143.73 $776,878 - $894,144	-6,221 Reduced 19.25%	26,093 $3.73 Million
Q1 2019 May 14, 2019	SELL	$97.62 - $132.29 $222,183 - $301,092	-2,276 Reduced 6.58%	32,314 $4.27 Million
Q3 2018 Nov 19, 2018	BUY	$98.13 - $108.9 $785 - $871	8 Added 0.02%	34,590 $3.76 Million
Q2 2018 Aug 08, 2018	BUY	$96.1 - $103.24 $128,101 - $137,618	1,333 Added 4.01%	34,582 $3.41 Million
Q1 2018 Apr 30, 2018	BUY	$92.16 - $103.8 $129,853 - $146,254	1,409 Added 4.43%	33,249 $3.26 Million
Q4 2017 Feb 07, 2018	SELL	$85.26 - $94.62 $113,481 - $125,939	-1,331 Reduced 4.01%	31,840 $2.73 Million
Q4 2017 Feb 07, 2018	BUY	$85.26 - $94.62 $113,481 - $125,939	1,331 Added 4.18%	33,171 $3.08 Million
Q3 2017 Nov 09, 2017	SELL	$79.29 - $88.45 $2.18 Million - $2.43 Million	-27,439 Reduced 46.29%	31,840 $2.73 Million
Q2 2017 Aug 14, 2017	BUY	N/A	59,279	59,279 $5 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $166B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.

Account

Financial Enhancement Group LLC Danaher Corp Transaction History